Related Experiment Video
Updated: Jan 23, 2026

Constructing and Visualizing Models using Mime-based Machine-learning Framework
Published on: July 22, 2025
Machine-learning to stratify diabetic patients using novel cardiac biomarkers and integrative genomics
Quincy A Hathaway1,2, Skyler M Roth3, Mark V Pinti4
1Division of Exercise Physiology, West Virginia University School of Medicine, PO Box 9227, 1 Medical Center Drive, Morgantown, WV, 26505, USA.
Insights
Machine learning identified novel biomarkers for predicting type 2 diabetes. Nuclear methylation and specific mitochondrial DNA markers showed high accuracy, improving upon HbA1c for personalized risk assessment.
Area of Science:
- Biomedical research
- Genomics
- Precision medicine
Background:
- Diabetes mellitus is a chronic disease with increasing prevalence.
- Diabetics have a 2-4x higher risk of cardiovascular disease.
- HbA1c has limitations in predicting long-term outcomes across diverse populations.
Purpose of the Study:
- To develop a precision medicine model for predicting diabetes mellitus development.
- To implement machine learning algorithms using cardiac biomarkers.
- To enhance personalized risk assessment beyond traditional HbA1c levels.
Main Methods:
- Machine learning, including SHapley Additive exPlanations (SHAP), was applied to patient data.
- Physiological, biochemical, and sequencing data from 50 patients (30 non-diabetic, 20 type 2 diabetic) were analyzed.
- Supervised learning models were validated using Logistic Regression, LDA, NB, SVM, and CART with cross-validation.
Main Results:
- Total nuclear methylation and mitochondrial electron transport chain (ETC) activities achieved ~84% accuracy in predicting diabetic status.
- Specific mitochondrial DNA single nucleotide polymorphisms (SNPs) in the D-Loop region were strongly associated with diabetes.
- CpG24 and CpG29 methylation within the TFAM gene correlated with diabetic progression, with combined methylation markers showing high diagnostic value.
Conclusions:
- Machine learning successfully identified novel and relevant biomarkers for type 2 diabetes.
- Integrating diverse datasets (physiological, biochemical, sequencing) enhances biomarker discovery.
- This approach can guide future research into disease pathogenesis and biomarker identification.
Background:
Diabetes mellitus is a chronic disease that impacts an increasing percentage of people each year. Among its comorbidities, diabetics are two to four times more likely to develop cardiovascular diseases. While HbA1c remains the primary diagnostic for diabetics, its ability to predict long-term, health outcomes across diverse demographics, ethnic groups, and at a personalized level are limited. The purpose of this study was to provide a model for precision medicine through the implementation of machine-learning algorithms using multiple cardiac biomarkers as a means for predicting diabetes mellitus development.
Methods:
Right atrial appendages from 50 patients, 30 non-diabetic and 20 type 2 diabetic, were procured from the WVU Ruby Memorial Hospital. Machine-learning was applied to physiological, biochemical, and sequencing data for each patient. Supervised learning implementing SHapley Additive exPlanations (SHAP) allowed binary (no diabetes or type 2 diabetes) and multiple classification (no diabetes, prediabetes, and type 2 diabetes) of the patient cohort with and without the inclusion of HbA1c levels. Findings were validated through Logistic Regression (LR), Linear Discriminant Analysis (LDA), Gaussian Naïve Bayes (NB), Support Vector Machine (SVM), and Classification and Regression Tree (CART) models with tenfold cross validation.
Results:
Total nuclear methylation and hydroxymethylation were highly correlated to diabetic status, with nuclear methylation and mitochondrial electron transport chain (ETC) activities achieving superior testing accuracies in the predictive model (~ 84% testing, binary). Mitochondrial DNA SNPs found in the D-Loop region (SNP-73G, -16126C, and -16362C) were highly associated with diabetes mellitus. The CpG island of transcription factor A, mitochondrial (TFAM) revealed CpG24 (chr10:58385262, P = 0.003) and CpG29 (chr10:58385324, P = 0.001) as markers correlating with diabetic progression. When combining the most predictive factors from each set, total nuclear methylation and CpG24 methylation were the best diagnostic measures in both binary and multiple classification sets.
Conclusions:
Using machine-learning, we were able to identify novel as well as the most relevant biomarkers associated with type 2 diabetes mellitus by integrating physiological, biochemical, and sequencing datasets. Ultimately, this approach may be used as a guideline for future investigations into disease pathogenesis and novel biomarker discovery.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Stratified Sampling Method
To choose a stratified sample, divide the population into groups called strata and then take a...
Genomics
Machines
A free-body diagram of the...
Classification of Epithelial Tissues: Stratified Epithelium
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

